Management of Inflammatory Rheumatic Conditions in the Elderly

Overview

Journal Rheumatology (Oxford)

Publisher Oxford University Press

Specialty Rheumatology

Date 2018 Jul 9

PMID 29982766

Citations 10

Authors

Clement Lahaye

Zuzana Tatar

Jean-Jacques Dubost

Anne Tournadre

Martin Soubrier

Affiliations

Soon will be listed here.

Abstract

The number of elderly people with chronic inflammatory rheumatic diseases is increasing. This heterogeneous and comorbid population is at particular risk of cardiovascular, neoplastic, infectious and iatrogenic complications. The development of biotherapies has paved the way for innovative therapeutic strategies, which are associated with toxicities. In this review, we have focused on the scientific and therapeutic changes impacting the management of elderly patients affected by RA, SpA or PsA. A multidimensional health assessment resulting in an integrated therapeutic strategy was identified as a major research direction for improving the management of elderly patients.

Citing Articles

Comprehensive analysis of rheumatic diseases, comorbidities, and mortality in geriatric population: Real-world data of 515 patients in a single rheumatology clinic.

Tekeoglu S Medicine (Baltimore). 2024; 103(48):e40753.

PMID: 39612436 PMC: 11608722. DOI: 10.1097/MD.0000000000040753.

CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry.

Funada M, Miyazaki Y, Nakayamada S, Sonomoto K, Kubo S, Miyagawa I RMD Open. 2024; 10(2).

PMID: 38866590 PMC: 11177696. DOI: 10.1136/rmdopen-2023-004049.

OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.

Brown A, Fisher L, Curtis H, Wiedemann M, Hulme W, Speed V Br J Clin Pharmacol. 2024; .

PMID: 38589944 PMC: 7616619. DOI: 10.1111/bcp.16062.

Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System.

Gaujoux-Viala C, Bergmann J, Goguillot M, Melaine A, Guerin M, Edouard A RMD Open. 2023; 9(4).

PMID: 37914177 PMC: 10619049. DOI: 10.1136/rmdopen-2023-003075.

Initiation of Disease-Modifying Antirheumatic Drugs in Older Medicare Beneficiaries With New Diagnosis of Late-Onset Rheumatoid Arthritis.

Lee J, Martindale J, Makris U, Singh N, Yung R, Bynum J ACR Open Rheumatol. 2023; 5(12):694-700.

PMID: 37872884 PMC: 10716804. DOI: 10.1002/acr2.11625.

References

Barnabe C, Martin B, Ghali W . Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010; 63(4):522-9. DOI: 10.1002/acr.20371. View

Soubrier M, Rosenbaum D, Tatar Z, Lahaye C, Dubost J, Mathieu S . Vascular effects of nonsteroidal antiinflammatory drugs. Joint Bone Spine. 2013; 80(4):358-62. DOI: 10.1016/j.jbspin.2012.12.002. View

Martin W, Shim M, Paulus H, Chaudhari S, Feng J, Elashoff D . Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry. J Clin Rheumatol. 2014; 20(6):301-5. PMC: 4560341. DOI: 10.1097/RHU.0000000000000152. View

Perlmutter A, Mittal A, Menter A . Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians. Br J Dermatol. 2008; 160(1):8-15. DOI: 10.1111/j.1365-2133.2008.08891.x. View

van den Bemt B, Zwikker H, van den Ende C . Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012; 8(4):337-51. DOI: 10.1586/eci.12.23. View

Cho S, Sung Y, Kim D, Won S, Choi C, Kim T . Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016; 17:333. PMC: 4977640. DOI: 10.1186/s12891-016-1185-6. View

Semerano L, Julia C, Aitisha O, Boissier M . Nutrition and chronic inflammatory rheumatic disease. Joint Bone Spine. 2016; 84(5):547-552. DOI: 10.1016/j.jbspin.2016.10.003. View

Palmowski Y, Buttgereit T, Dejaco C, Bijlsma J, Matteson E, Voshaar M . "Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements. Arthritis Care Res (Hoboken). 2016; 69(8):1134-1141. DOI: 10.1002/acr.23185. View

Agca R, Heslinga S, Rollefstad S, Heslinga M, McInnes I, Peters M . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016; 76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775. View

10.

Gioxari A, Kaliora A, Marantidou F, Panagiotakos D . Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis. Nutrition. 2017; 45:114-124.e4. DOI: 10.1016/j.nut.2017.06.023. View

11.

Wu C, Chen D, Shen J, Ho H, Chen C, Kuo K . The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study. Arthritis Res Ther. 2014; 16(5):449. PMC: 4201718. DOI: 10.1186/s13075-014-0449-5. View

12.

Alarcon G, Kremer J, Macaluso M, Weinblatt M, Cannon G, Palmer W . Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med. 1997; 127(5):356-64. DOI: 10.7326/0003-4819-127-5-199709010-00003. View

13.

Wendler J, Burmester G, Sorensen H, Krause A, Richter C, Tony H . Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients. Arthritis Res Ther. 2014; 16(2):R80. PMC: 4060207. DOI: 10.1186/ar4521. View

14.

Tikkanen P, Lonnroos E, Sipila S, Nykanen I, Sulkava R, Hartikainen S . Effects of comprehensive geriatric assessment-based individually targeted interventions on mobility of pre-frail and frail community-dwelling older people. Geriatr Gerontol Int. 2014; 15(1):80-8. DOI: 10.1111/ggi.12231. View

15.

McElhaney J, Effros R . Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol. 2009; 21(4):418-24. PMC: 2725188. DOI: 10.1016/j.coi.2009.05.023. View

16.

Fleischmann R, Alam J, Arora V, Bradley J, Schlichting D, Muram D . Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis. RMD Open. 2017; 3(2):e000546. PMC: 5640108. DOI: 10.1136/rmdopen-2017-000546. View

17.

Richards B, Whittle S, Buchbinder R . Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2011; (11):CD008920. DOI: 10.1002/14651858.CD008920.pub2. View

18.

Filippini M, Bazzani C, Atzeni F, Sarzi Puttini P, Marchesoni A, Favalli E . Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry. Biomed Res Int. 2014; 2014:416892. PMC: 4109221. DOI: 10.1155/2014/416892. View

19.

Smith T, Pelpola K, Ball M, Ong A, Myint P . Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis. Age Ageing. 2014; 43(4):464-71. DOI: 10.1093/ageing/afu065. View

20.

Lavan A, Gallagher P, OMahony D . Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016; 11:857-66. PMC: 4922820. DOI: 10.2147/CIA.S80280. View